Association of PPARG and LPIN1 gene polymorphisms with metabolic syndrome and type 2 diabetes

Medicinski Glasnik

Volumn 8, Issue 1, 2011, Pages 76-83

  Bego, Tamer ^a   Dujic, Tanja ^a   Mlinar, Barbara ^b   Semiz, Sabina ^a   Malenica, Maja ^a   Prnjavorac, Besim ^a,c   Ostanek, Barbara ^b   Marc, Janja ^b   Čaušević, Adlija ^a  

^a UNIVERSITY OF SARAJEVO   (Bosnia and Herzegovina)

^b UNIVERSITY OF LJUBLJANA   (Slovenia)

^c General Hospital Te anj   (Bosnia and Herzegovina)

Author keywords

LPIN1; Metabolic syndrome; PPARG; Type 2 diabetes

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LIPIN 1; LIVER ENZYME; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PLASMA PROTEIN; PROTEIN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADIPOCYTE; ARTICLE; CELL DIFFERENTIATION; DNA POLYMORPHISM; GENETIC ASSOCIATION; GENETIC VARIABILITY; HUMAN; LIPID METABOLISM; MAJOR CLINICAL STUDY; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PATHOGENESIS;

CHOLESTEROL, HDL; CHOLESTEROL, LDL; DIABETES MELLITUS, TYPE 2; HUMANS; INSULIN; METABOLIC SYNDROME X; PHOSPHATIDATE PHOSPHATASE; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PPAR GAMMA;

EID: 79551703619     PISSN: 18400132     EISSN: 18402445     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Eckel RH, Grudy SM, Zimmet PZ. The metabolic syndrome. Lancet 2005; 365:1415-28. (Pubitemid 40523737)
2. Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr, Lenfant C. Definition of metabolic syndrome: Report of the National Heart, Lung and Blood Institute / American Heart Association conference on scientific issues related to definition. Circulation 2004; 109:433-8.
3. International Diabetes Federation. The IDF consensus worldwide definition of the metabolic syndrome. Exp Clin Endocrinol Diabetes 2001; 109:548-59.
4. Ginsberg HN. Treatment for patients with the metabolic syndrome. Am J Cardiol 2003; 3:29-39.
5. Keltikangas-Jarvinen L, Ravaja N, Raikkonen K, Hautanen A, Adlercreutz H. Relationships between the pituitary-adrenal hormones, insulin, and glucose in middle-aged men: moderating influence of psychosocial stress. Metabolism 1998; 47:1440-9. (Pubitemid 28565525)
6. Raikkonen K, Matthews KA, Kuller LH. The relationship between psychological risk attributes and the metabolic syndrome in healthy women: antecedent or consequence? Metabolism 2002; 51:1573-7.
7. Keller KB, Lemberg L. Obesity and the metabolic syndrome. Am J Crit Care 2003; 12: 167-70.
8. Sathyaprakash R, Henry RR. Preventing diabetes by treating aspects of the metabolic syndrome. Curr Diab Rep 2002; 2:416-22.
9. Teran-Garcia M, Bouchard C. Genetics of the metabolic syndrome. Appl Physiol Nutr Metab 2007; 32:89-114.
10. Mlinar B, Marc J, Janez A, Pfeifer M. Molecular mechanisms of insulin resistance and associated diseases. Clin Chim Acta 2007; 375:20-35.
11. End AT, Rao DC, Weder AB, Cooper R, Curb JD, Hanis CL, Turner ST, de Andrade M, Hsiung CA, Quertermous T, Zhu X, Province MA. Two major QTLs and several others relate to factors of metabolic syndrome in the family blood pressure program. Hypertension 2005; 46:751-7. (Pubitemid 43186749)
12. Tonstad S, Hjermann I. A high risk score for coronary heart disease is associated with the metabolic syndrome in a 40-year-old men and women. J Cardiovasc Risk 2003; 10:129-35.
13. Wamala SP, Lynch J, Horsten M, Mittleman MA, Schenck-Gustafsson K, Orth-Gomer K. Education and the metabolic syndrome in women. Diabetes Care 2000; 23:1444-5.
14. Semple RK, Chatterjee O'Rahilly S. PPARγ and human metabolic disease. J. Clin. Invest 2006; 116:581-589.
15. Bell-Parikh LC, Ide T, Lawson JA, McNamara P, Reilly M, FitzGerald GA. Biosynthesis of 15-deoxy-delta12,14-PGJ2 and the ligation of PPARgamma. J Clin Invest 2003; 112:945-55.
16. Hui Zhang, Aihua Zhang, Donald E. Kohan, Raoul D. Nelson, Frank J. Gonzalez, and Tianxin Yang. Collecting duct-specific deletion of peroxisome proliferator-activated receptor gamma blocks thiazolidinedioneinduced fluid retention. Proc Natl Acad Sci USA 2005; 102:9406-11.
17. Larsen TM, Toubro S, Astrup A. PPARgamma agonists in the treatment of type II diabetes: is increased fatness commensurate with long-term efficacy? Int J Obesity Relat Metab Disord 2003; 27:147-61.
18. Lusis AJ, Attie AD, Reuel K. Metabolic syndrome: from epidemiology to systems biology. Nat. Rev. Genet 2008; 9:819-30.
19. Péterfy M, Phan J, Xu P, Reue K. Lipodystrophy in the fld mouse results from mutation of a new gene encoding a nuclear protein, lipin. Nat. Genet 2001; 27:121-4. (Pubitemid 32044532)
20. Péterfy M, Phan J, Reuel K. Alternatively spliced Lipine isoforms exhibit distinct expression pattern, subcellular localization, and role in adipogenesis. J Biol Chem 2005; 280:32883-9. (Pubitemid 41368337)
21. Reuel K, Donkor J. Lipine: a determinant of adiposity, insulin sensitivity and energy balance. Future lipidology 2006; 1:91-101.
22. Donkor J, Sariahmetoglu M, Dewald J, Brindley DN, Reuel K. Three mammalian lipins act as phosphatidate phosphatases with distinct tissue expression patterns. J Biol Chem 2007; 282:3450-7. (Pubitemid 47084457)
23. Carman GM, and GS Han. Phosphatidic acid phosphatase, a key enzyme in the regulation of lipid synthesis. J. Biol. Chem 2009; 284:2593-7.
24. Harris TE, TA Huffman, A Chi J. Shabanowitz DF, Hunt A. Kumar, and JC Lawrence Jr. Insulin controls subcellular localization and multisite phosphorylation of the phosphatidic acid phosphatase, lipin 1. J Biol Chem 2007; 282:277-86. (Pubitemid 47076630)
25. Finck, B. N, MC Gropler, Z Chen, TC Leone, MA Croce, TE Harris, JC Lawrence Jr, and DP Kelly. Lipin 1 is an inducible amplifier of the hepatic PGC-1alpha/PPARalpha regulatory pathway. Cell Metab 2006; 4:199-210. (Pubitemid 44283957)
26. Suviolahti E, Reuel K, Cantor RM, Phan J, Gentile Met al. Cross Species Analyses implicitly Lipine 1 Involvement in human glucose metabolism. Hum Mol Genet 2006; 15:377-86.
27. Brinton EA. Lipid abnormalities in the metabolic syndrome. Curr Diab Rep 2003; 3:65-72. (Pubitemid 38906767)
28. Loos RJF, Rankinen T, Pérusse L, Tremblay A, Després J-P, Bouchard C. Association of lipin 1 gene polymorphisms with measures of energy and glucose metabolism. Obesity 2007; 15:2723-32.
29. Wiedmann S, Fischer M, Koehler M, Neureuther K, Riegger G, Doering A, Schunkert H, Hengstenberg C, Baessler A. Genetic variants within the LPIN1 gene, encoding lipin, are influencing phenotypes of the metabolic syndrome in humans. Diabetes 2007. 57:209-17.
30. Nestler JE, Powers LP, Matt DW, Steingold KA, Plymate SR, Rittmaster RS, Clore JN, Blackard WG.. A direct effect ofhyperinsulinemia on serum sex hormone-binding globulin levels in obese women with the polycystic ovary syndrome. J Clin Endocrinol Metab 1991; 72:83-9. (Pubitemid 21921660)
31. Bluher M, Lubben G, Paschke R. Analysis of the relationship between the between Pro12Ala variant in the PPAR-gamma2 gene and the response rate to therapy with pioglitazone in patients with type 2 diabetes. Diabetes Care 2003; 26:825-31. (Pubitemid 36929350)
32. Meirhaeghe A, Fajas L, Gouilleux F, Cottel D, Helbecque N, Auwerx J, Amouyel P. A functional polymorphism in a STAT5B site of the human PPAR gamma 3 gene promoter affects height and lipid metabolism in a French population. Arterioscler Thromb Vasc Biol 2003; 23:289-94. (Pubitemid 36231942)
33. Altshuler D, Hirschhorn JN, Klannemark M, Lindgren CM, Vöhl MC, Nemesh J, Lane CR, Schaffner SF, Bolk S, Brewer C, Tuomi T, Gaudet D, Hudson TJ, Daly M, Groop L, Lander ES. The common PPARgamma between Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nat Genet 2000; 26:76-80.
34. Yamauchi T, Kamon J, Waki H, Murakami K, Motojima K, Komeda K, Ide T, Kubota N, Terauchi Y, Tobe K, Miki H, Tsuchida A, Akanuma Y, Nagai R, Kimura S, Kadowaki T. The mechanisms by which both heterozygous peroxisome proliferator-activated receptor gamma (PPARgamma) deficiency and PPARgamma agonist improve insulin resistance. J Biol Chem 2001; 276:41245-54.
35. Meirhaeghe A, Amouyel P. Impact of genetic variation of PPARgamma in humans. Mol Genet Metab 2004; 83:93-102. (Pubitemid 39311284)
36. Tok EC, Aktas A, Ertunc D, Erdal EM, Dilek S. Evaluation of glucose metabolism and reproductive hormones in polycystic ovary syndrome on the basis of peroxisome proliferator-activated receptor (PPAR)-gamma2 between Pro12Ala genotype. Hum Reprod 2005; 20:1590-5. (Pubitemid 40852253)
37. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988; 16:1215.